Literature DB >> 8950734

Neonatal early onset group B streptococcal infection. A nine-year retrospective study in a tertiary care hospital.

A H Adriaanse1, I Lagendijk, H L Muytjens, J G Nijhuis, L A Kollée.   

Abstract

Retrospectively, morbidity and mortality of neonatal early onset group B streptococcal (GBS) infection were established. Risk factors and prognostic factors were determined. Between 1985 and 1993, 78 patients with early onset GBS disease were identified. The overall mortality rate was 23%. In 60 of 73 cases (82%) at least one of the investigated risk factors was present. Low birth weight was not an independent risk factor. Outcome of 44 of 60 survivors (73%) at the age of at least one year was obtained. Almost 30% of them had sequelae. The most important were spastic disorders and delayed psychomotor development. In 42% of patients with symptoms of GBS-infection within six hours after birth sequelae occurred. There were no sequelae among patients with symptoms after 6 hours. All 9 severely brain damaged infants showed symptoms shortly after birth. Mortality and adverse outcome rate were higher in infants with low gestational age or low 5 minute Apgar scores. Early treatment resulted in less mortality, but not in less sequelae. GBS-sepsis still causes significant mortality and leaves a substantial number of survivors damaged. Alertness to GBS-infection, even in the absence of risk factors, remains crucial for early treatment and good outcome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950734     DOI: 10.1515/jpme.1996.24.5.531

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  3 in total

1.  Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention.

Authors:  M Trijbels-Smeulders; G A de Jonge; P C M Pasker-de Jong; L J Gerards; A H Adriaanse; R A van Lingen; L A A Kollée
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-01-16       Impact factor: 5.747

Review 2.  Molecular-based screening for perinatal group B streptococcal infection: implications for prevention and therapy.

Authors:  Stéphane Emonet; Jacques Schrenzel; Begoña Martinez de Tejada
Journal:  Mol Diagn Ther       Date:  2013-12       Impact factor: 4.074

Review 3.  Antibiotic use and misuse during pregnancy and delivery: benefits and risks.

Authors:  Begoña Martinez de Tejada
Journal:  Int J Environ Res Public Health       Date:  2014-08-07       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.